(Q93158347)
Statements
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial (English)
Maria Rita Castellani
1 reference
Ulrike Pötschger
Ruth Ladenstein
Dominique Valteau-Couanet
Roberto Luksch
Victoria Castel
Isaac Yaniv
Genevieve Laureys
Penelope Brock
Jean Marie Michon
Cormac Owens
Godfrey Chi Fung Chan
Ellen Ruud
Henrik Schroeder
Guenter Schreier
Hans Loibner
Keith Holmes
Mark N Gaze
Andrew D J Pearson